cbdMD Financials - Benzinga

SPY767.92+0.49%QQQ743.52+0.76%BTC/USD84,299.08+0.80%DIA512.19−0.13%GLD381.36−0.40%TLT77.68−0.71%

cbdMD Inc

YCBDAMEX

Trade with Public

Trade with Public

$0.4576

-0.0114-2.44%

Last update: Sep 30, 12:12 PM

PRO

Why Is It Moving?™:Shares of cannabis-related companies are trading lower following a report s...

Overview News Earnings Forecast Price TargetsFinancialsSentiment Ownership Compare Stock Report

cbdMD Financials

cbdMD (YCBD) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
cbdMD Q3 EPS $(0.11) Misses $(0.03) Estimate, Sales $5.555M Miss $5.689M Estimate

Benzinga Newsdesk

PRO
cbdMD Q2 EPS $(0.08) Misses $(0.05) Estimate, Sales $5.640M Beat $5.292M Estimate

cbdMD (AMEX:YCBD) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.05) by 60 percent. This is a 95.79 percent increase over losses of $(1.90) per share from the same

Benzinga Newsdesk

Earnings Scheduled For May 14, 2026

Benzinga Insights

cbdMD Q1 Earnings Report: What Investors Need to Know

Benzinga Insights

PRO
cbdMD Q1 EPS $(0.04) Beats $(0.06) Estimate, Sales $5.017M Beat $4.858M Estimate

cbdMD (AMEX:YCBD) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.06) by 33.33 percent. This is a 97.73 percent increase over losses of $(1.76) per share from the same

Benzinga Newsdesk

Earnings Scheduled For February 17, 2026

Benzinga Insights